Lexaria Bioscience (LEXX) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Lexaria Bioscience (LEXX) over the last 15 years, with Q4 2025 value amounting to -$4.8 million.
- Lexaria Bioscience's Enterprise Value rose 4335.48% to -$4.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$4.8 million, marking a year-over-year increase of 4335.48%. This contributed to the annual value of -$2.3 million for FY2025, which is 6635.92% up from last year.
- Per Lexaria Bioscience's latest filing, its Enterprise Value stood at -$4.8 million for Q4 2025, which was up 4335.48% from -$2.3 million recorded in Q3 2025.
- Lexaria Bioscience's 5-year Enterprise Value high stood at -$1.8 million for Q3 2023, and its period low was -$12.0 million during Q3 2021.
- In the last 5 years, Lexaria Bioscience's Enterprise Value had a median value of -$6.7 million in 2022 and averaged -$6.5 million.
- In the last 5 years, Lexaria Bioscience's Enterprise Value tumbled by 175364.73% in 2021 and then surged by 7156.41% in 2023.
- Lexaria Bioscience's Enterprise Value (Quarter) stood at -$11.6 million in 2021, then soared by 55.78% to -$5.1 million in 2022, then surged by 53.31% to -$2.4 million in 2023, then plummeted by 254.64% to -$8.5 million in 2024, then surged by 43.35% to -$4.8 million in 2025.
- Its last three reported values are -$4.8 million in Q4 2025, -$2.3 million for Q3 2025, and -$5.0 million during Q2 2025.